Endometriosis
Not recruitingA study testing vipoglanstat for women with moderate to severe endometriosis-related pain
- Disease:Endometriosis
- Substances:GS-248VIPOGLANSTAT
Bulgaria- Participants:18–64 years
- Substances:GS-248
- Sponsor:Gesynta Pharma AB
Rare diseases
Investigational molecules
Locations
Wallingatan 24, Adolf Fredrik, 111 24 Stockholm, Sweden
Clinical research is centred on endometriosis-related pain, with particular attention to non-menstrual pelvic pain and the broader burden of persistent symptoms in women affected by the condition.
The sponsor’s current research activity is focused on therapeutic areas relevant to symptom control in gynaecological disorders, with clinical work spanning multiple collaborating sites across Europe.
Gesynta Pharma AB runs clinical trials in conditions such as Endometriosis, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.